SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Maternal-Fetal Medicine Consultation — Charlotte Brontë

PatientCharlotte Brontë
Date of birth1987-04-21
IdentifiersMRN HR-NI025-SYN; SSN (made up) 000-25-3804
Document date2026-01-20
AuthorMargaret Oyelaran-Hughes, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

First pregnancy at 38, at 7 weeks 1 day by today's dating scan, with moderate nausea and vomiting for a week and early weight loss. Please advise on the plan if it worsens, on aneuploidy screening and diagnostic options at her age, on preeclampsia prevention, and on her tuberculosis risk. [S]

Urgency: Soon, within one to two weeks; same-day review here if she cannot keep fluids down. [S]

Questions for the consultant:

History of Present Illness

Ms. Brontë is seen at the request of Dr. Thwaite at 8 weeks 1 day. Nausea has worsened over the week despite doxylamine-pyridoxine two tablets at bedtime: she vomits four or five times a day, keeps down small amounts of fluid and dry food most days, and feels lightheaded only on standing quickly. PUQE-24 score 11. She has had no pain, bleeding, fever, or diarrhea, and no palpitations or tremor. This is a planned first pregnancy; she has no previous pregnancies, no chronic illness, and no thyroid disease. Her elder sisters died of tuberculosis in childhood and two other sisters as young adults, in her household; she has no cough, night sweats, or fever. She is anxious about carrying a pregnancy at her age after losing her mother and sisters young, and wants clear information. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

10 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Folic acid 0.4 mg oral tablet, one tablet by mouth daily (replacing an iron-containing prenatal vitamin while nausea is severe)One tablet by mouth dailyOral route2026-01-13activeS
Doxylamine 10 mg and pyridoxine 10 mg delayed-release tablet, two tablets by mouth at bedtimeTwo tablets by mouth at bedtimeOral route2026-01-13 to 2026-01-20completedS
Doxylamine 10 mg and pyridoxine 10 mg delayed-release tablet, one tablet in the morning, one mid-afternoon, and two at bedtime (four a day)One tablet in the morning, one mid-afternoon, and two at bedtimeOral route2026-01-20activeS
Metoclopramide 10 mg oral tablet, one tablet by mouth three times a day before mealsOne tablet by mouth three times a day, 30 minutes before mealsOral route2026-01-20 to 2026-01-29completedS

Problems

ProblemClinical statusVerificationCodeProvenance
First pregnancy at 38 (elderly primigravida), single live intrauterine pregnancy dated by ultrasound at 7 weeks 1 dayactiveconfirmed O09.519S — Synthetic modern prenatal care anchored to the documented report that she was pregnant when she died; the pregnancy itself is questioned in one source (CLM-0019).
Nausea and vomiting of pregnancy, moderate (PUQE-24 score 10), with early weight loss, under evaluation for hyperemesis gravidarumactiveconfirmed O21.9S — Synthetic presenting concern at the index visit, superseded by the hyperemesis gravidarum diagnosis at the sick visit; her documented "perpetual nausea" is D and the hyperemesis reading of it is R.

Physical Exam

Vital signs recorded on 2026-01-20; see the referring visit's Vital Signs section. [S]

SystemFinding
GeneralSlight and tired; not distressed
HydrationMucous membranes slightly dry; no orthostatic drop; pulse 92; blood pressure 102/64 mmHg
NeckThyroid not enlarged
AbdomenSoft and non-tender

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-01-20Sodium [Moles/volume] in Serum or Plasma136mmol/L135-145 mmol/LNormalS
2026-01-20Potassium [Moles/volume] in Serum or Plasma3.6mmol/L3.5-5.1 mmol/LNormalS
2026-01-20Chloride [Moles/volume] in Serum or Plasma99mmol/L98-107 mmol/LNormalS
2026-01-20Carbon dioxide, total [Moles/volume] in Serum or Plasma26mmol/L22-29 mmol/LNormalS
2026-01-20Urea nitrogen [Mass/volume] in Serum or Plasma11mg/dL6-20 mg/dLNormalS
2026-01-20Creatinine [Mass/volume] in Serum or Plasma0.58mg/dL0.4-0.9 mg/dLNormalS
2026-01-20Glucose [Mass/volume] in Serum or Plasma74mg/dL70-99 mg/dLNormalS
2026-01-20Ketones [Mass/volume] in Urine by Test strip40mg/dL<=0 mg/dLHighS

Assessment

Data reviewed: Today's weight (44.0 kg, 4.3 percent below her pre-pregnancy weight), vital signs, and metabolic panel (normal, potassium 3.6 mmol/L); the dating scan; the first prenatal tests (blood group O RhD positive, antibody screen negative, rubella immune, hepatitis B, HIV, syphilis, and hepatitis C negative, urine culture no growth); the interferon-gamma release assay (negative); PHQ-9 5. [S]

Plan of Treatment